_id
6911b6cdccc777a4e85d607a
Ticker
FSPM
Name
Fusion Pharm Inc
Exchange
OTCCE
Address
5850 East 58th Avenue, Commerce City, CO, United States, 80022
Country
USA
Sector
Healthcare
Industry
Pharmaceutical Retailers
Currency
USD
Website
https://www.fusionpharminc.com
Description
FusionPharm, Inc. develops, manufactures, and sells a line of cultivation containers under the PharmPod brand name in the United States. Its PharmPods cultivation container system is used in the indoor plant cultivation. The company also offers its products to businesses, universities, and individuals to cultivate various plants. FusionPharm, Inc. was formerly known as Baby Bee Bright Corp. and changed its name to FusionPharm, Inc. in April 2011. The company was founded in 1998 and is based in Commerce City, Colorado.
Last Close
0.0001
Volume
375
Current Price
0.0001
Change
0
Last Updated
2026-01-03T12:08:55.704Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
1059
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2014-03-31
Revenue
304577
Cost Of Revenue
227072
Gross Profit
77505
Operating Expenses
0
Operating Income
-29917
Interest Expense
2220
Pretax Income
-47795
Net Income
-47795
Eps
-
Dividends Per Share
-
Shares Outstanding
10591500
Income Tax Expense
0
EBITDA
-
Operating Margin
-9.822475104817501
Total Other Income Expense Net
-15658
Cash
674388
Short Term Investments
-
Receivables
39076
Inventories
473559
Total Current Assets
1187023
Property Plant Equipment
49795
Total Assets
1292288
Payables
98503
Short Term Debt
45550
Long Term Debt
-
Total Liabilities
458513
Equity
833775
Bs_currency_symbol
USD
Depreciation
2583
Change In Working Capital
-
Cash From Operations
-488035
Capital Expenditures
34738
Cash From Investing
-64408
Cash From Financing
1010000
Net Change In Cash
457557
Cf_currency_symbol
USD
PE
-
PB
-
ROE
-5.732361848220443
ROA
-3.6984789768225035
FCF
-522773
Fcf Percent
-1.716390272410589
Piotroski FScore
0
Health Score
31
Deep Value Investing Score
4
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
4
Growth Investing Score
3
Momentum Investing Score
4.5
Net Net Investing Score
8
Quality Investing Score
2.5
Value Investing Score
2.5
Quarters > 0 > quarter
2014-03-31
Quarters > 0 > income Statement > revenue
304577
Quarters > 0 > income Statement > cost Of Revenue
227072
Quarters > 0 > income Statement > gross Profit
77505
Quarters > 0 > income Statement > operating Expenses
0
Quarters > 0 > income Statement > operating Income
-29917
Quarters > 0 > income Statement > interest Expense
2220
Quarters > 0 > income Statement > pretax Income
-47795
Quarters > 0 > income Statement > net Income
-47795
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-9.822475104817501
Quarters > 0 > income Statement > total Other Income Expense Net
-15658
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
674388
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
39076
Quarters > 0 > balance Sheet > inventories
473559
Quarters > 0 > balance Sheet > total Current Assets
1187023
Quarters > 0 > balance Sheet > property Plant Equipment
49795
Quarters > 0 > balance Sheet > total Assets
1292288
Quarters > 0 > balance Sheet > payables
98503
Quarters > 0 > balance Sheet > short Term Debt
45550
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
458513
Quarters > 0 > balance Sheet > equity
833775
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-47795
Quarters > 0 > cash Flow > depreciation
2583
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-488035
Quarters > 0 > cash Flow > capital Expenditures
34738
Quarters > 0 > cash Flow > cash From Investing
-64408
Quarters > 0 > cash Flow > cash From Financing
1010000
Quarters > 0 > cash Flow > net Change In Cash
457557
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-5.732361848220443
Quarters > 0 > ratios > ROA
-3.6984789768225035
Quarters > 0 > ratios > FCF
-522773
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-1.716390272410589
Quarters > 0 > health Score
31
Quarters > 1 > quarter
2013-12-31
Quarters > 1 > income Statement > revenue
44672
Quarters > 1 > income Statement > cost Of Revenue
175213
Quarters > 1 > income Statement > gross Profit
-130541
Quarters > 1 > income Statement > operating Expenses
0
Quarters > 1 > income Statement > operating Income
-100040
Quarters > 1 > income Statement > interest Expense
22876
Quarters > 1 > income Statement > pretax Income
-112975
Quarters > 1 > income Statement > net Income
-112975
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-223.94340974212034
Quarters > 1 > income Statement > total Other Income Expense Net
9941
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2168
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
420
Quarters > 1 > balance Sheet > inventories
1013
Quarters > 1 > balance Sheet > total Current Assets
3601
Quarters > 1 > balance Sheet > property Plant Equipment
176
Quarters > 1 > balance Sheet > total Assets
4035
Quarters > 1 > balance Sheet > payables
1397
Quarters > 1 > balance Sheet > short Term Debt
1202
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
6228
Quarters > 1 > balance Sheet > equity
-2193
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-112975
Quarters > 1 > cash Flow > depreciation
9056
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
220758
Quarters > 1 > cash Flow > capital Expenditures
5545
Quarters > 1 > cash Flow > cash From Investing
-28551
Quarters > 1 > cash Flow > cash From Financing
6704
Quarters > 1 > cash Flow > net Change In Cash
198911
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
5151.618787049703
Quarters > 1 > ratios > ROA
-2799.8760842627016
Quarters > 1 > ratios > FCF
215213
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
4.817626253581662
Quarters > 1 > health Score
60
Quarters > 2 > quarter
2013-09-30
Quarters > 2 > income Statement > revenue
47825
Quarters > 2 > income Statement > cost Of Revenue
33101
Quarters > 2 > income Statement > gross Profit
14724
Quarters > 2 > income Statement > operating Expenses
0
Quarters > 2 > income Statement > operating Income
41842
Quarters > 2 > income Statement > interest Expense
4878
Quarters > 2 > income Statement > pretax Income
45644
Quarters > 2 > income Statement > net Income
45644
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
87.48980658651332
Quarters > 2 > income Statement > total Other Income Expense Net
-1076
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
16439
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
500000
Quarters > 2 > balance Sheet > inventories
6651
Quarters > 2 > balance Sheet > total Current Assets
523090
Quarters > 2 > balance Sheet > property Plant Equipment
51308
Quarters > 2 > balance Sheet > total Assets
676577
Quarters > 2 > balance Sheet > payables
48052
Quarters > 2 > balance Sheet > short Term Debt
26205
Quarters > 2 > balance Sheet > long Term Debt
105750
Quarters > 2 > balance Sheet > total Liabilities
180007
Quarters > 2 > balance Sheet > equity
496570
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
45644
Quarters > 2 > cash Flow > depreciation
-5614
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
6314
Quarters > 2 > cash Flow > capital Expenditures
5545
Quarters > 2 > cash Flow > cash From Investing
6369
Quarters > 2 > cash Flow > cash From Financing
-15960
Quarters > 2 > cash Flow > net Change In Cash
-3277
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
9.19185613307288
Quarters > 2 > ratios > ROA
6.746312688725747
Quarters > 2 > ratios > FCF
769
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
0.016079456351280712
Quarters > 2 > health Score
51
Quarters > 3 > quarter
2013-06-30
Quarters > 3 > income Statement > revenue
330300
Quarters > 3 > income Statement > cost Of Revenue
180599
Quarters > 3 > income Statement > gross Profit
149701
Quarters > 3 > income Statement > operating Expenses
0
Quarters > 3 > income Statement > operating Income
28105
Quarters > 3 > income Statement > interest Expense
4878
Quarters > 3 > income Statement > pretax Income
15798
Quarters > 3 > income Statement > net Income
15798
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
8.508931274598849
Quarters > 3 > income Statement > total Other Income Expense Net
-12307
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
3437
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
500000
Quarters > 3 > balance Sheet > inventories
37660
Quarters > 3 > balance Sheet > total Current Assets
541097
Quarters > 3 > balance Sheet > property Plant Equipment
56673
Quarters > 3 > balance Sheet > total Assets
634395
Quarters > 3 > balance Sheet > payables
86746
Quarters > 3 > balance Sheet > short Term Debt
29655
Quarters > 3 > balance Sheet > long Term Debt
240053
Quarters > 3 > balance Sheet > total Liabilities
356454
Quarters > 3 > balance Sheet > equity
277941
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
15798
Quarters > 3 > cash Flow > depreciation
-5614
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-18996
Quarters > 3 > cash Flow > capital Expenditures
5545
Quarters > 3 > cash Flow > cash From Investing
12837
Quarters > 3 > cash Flow > cash From Financing
9256
Quarters > 3 > cash Flow > net Change In Cash
3097
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
5.683940116787375
Quarters > 3 > ratios > ROA
2.4902466129146665
Quarters > 3 > ratios > FCF
-24541
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-0.07429912201029368
Quarters > 3 > health Score
33
Annuals > 0 > quarter
2013-12-31
Annuals > 0 > income Statement > revenue
594397
Annuals > 0 > income Statement > cost Of Revenue
473895
Annuals > 0 > income Statement > gross Profit
120502
Annuals > 0 > income Statement > operating Expenses
0
Annuals > 0 > income Statement > operating Income
-10148
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-42080
Annuals > 0 > income Statement > net Income
-42080
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-1.7072764499147877
Annuals > 0 > income Statement > total Other Income Expense Net
-9056
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
2168
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
420
Annuals > 0 > balance Sheet > inventories
1013
Annuals > 0 > balance Sheet > total Current Assets
3601
Annuals > 0 > balance Sheet > property Plant Equipment
176
Annuals > 0 > balance Sheet > total Assets
4035
Annuals > 0 > balance Sheet > payables
1397
Annuals > 0 > balance Sheet > short Term Debt
1202
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
6228
Annuals > 0 > balance Sheet > equity
-2193
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-42080
Annuals > 0 > cash Flow > depreciation
9056
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
239836
Annuals > 0 > cash Flow > capital Expenditures
5545
Annuals > 0 > cash Flow > cash From Investing
-23345
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
216491
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
1918.8326493388054
Annuals > 0 > ratios > ROA
-1042.8748451053284
Annuals > 0 > ratios > FCF
234291
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.3941658521156735
Annuals > 0 > health Score
60
Annuals > 1 > quarter
2012-12-31
Annuals > 1 > income Statement > revenue
308398
Annuals > 1 > income Statement > cost Of Revenue
222723
Annuals > 1 > income Statement > gross Profit
85675
Annuals > 1 > income Statement > operating Expenses
0
Annuals > 1 > income Statement > operating Income
-186547
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-234784
Annuals > 1 > income Statement > net Income
-234784
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-60.48904337901024
Annuals > 1 > income Statement > total Other Income Expense Net
-21746
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
3
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
66
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
69
Annuals > 1 > balance Sheet > property Plant Equipment
677
Annuals > 1 > balance Sheet > total Assets
911
Annuals > 1 > balance Sheet > payables
1071
Annuals > 1 > balance Sheet > short Term Debt
311
Annuals > 1 > balance Sheet > long Term Debt
2635
Annuals > 1 > balance Sheet > total Liabilities
4393
Annuals > 1 > balance Sheet > equity
-3482
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-234784
Annuals > 1 > cash Flow > depreciation
15019
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-100496
Annuals > 1 > cash Flow > capital Expenditures
6201
Annuals > 1 > cash Flow > cash From Investing
-8699
Annuals > 1 > cash Flow > cash From Financing
80000
Annuals > 1 > cash Flow > net Change In Cash
-29195
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
6742.791499138426
Annuals > 1 > ratios > ROA
-25772.118551042808
Annuals > 1 > ratios > FCF
-106697
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.34597176375981686
Annuals > 1 > health Score
40
Annuals > 2 > quarter
2011-12-31
Annuals > 2 > income Statement > revenue
256895
Annuals > 2 > income Statement > cost Of Revenue
222704
Annuals > 2 > income Statement > gross Profit
34191
Annuals > 2 > income Statement > operating Expenses
544803
Annuals > 2 > income Statement > operating Income
-287908
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-287564
Annuals > 2 > income Statement > net Income
-287564
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
0
Annuals > 2 > income Statement > shares Outstanding
0
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-112.07224741625956
Annuals > 2 > income Statement > total Other Income Expense Net
344
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
32940
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
29479
Annuals > 2 > balance Sheet > inventories
25427
Annuals > 2 > balance Sheet > total Current Assets
95026
Annuals > 2 > balance Sheet > property Plant Equipment
76296
Annuals > 2 > balance Sheet > total Assets
171322
Annuals > 2 > balance Sheet > payables
21200
Annuals > 2 > balance Sheet > short Term Debt
0
Annuals > 2 > balance Sheet > long Term Debt
269497
Annuals > 2 > balance Sheet > total Liabilities
344902
Annuals > 2 > balance Sheet > equity
-173729
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-287564
Annuals > 2 > cash Flow > depreciation
0.24
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-236290
Annuals > 2 > cash Flow > capital Expenditures
89649
Annuals > 2 > cash Flow > cash From Investing
-76296
Annuals > 2 > cash Flow > cash From Financing
345527
Annuals > 2 > cash Flow > net Change In Cash
32940
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
0
Annuals > 2 > ratios > ROE
165.52446626642646
Annuals > 2 > ratios > ROA
-167.85001342501255
Annuals > 2 > ratios > FCF
-325939
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.268763502598338
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2010-12-31
Annuals > 3 > income Statement > revenue
210
Annuals > 3 > income Statement > cost Of Revenue
83
Annuals > 3 > income Statement > gross Profit
127
Annuals > 3 > income Statement > operating Expenses
7726
Annuals > 3 > income Statement > operating Income
-7516
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
870602
Annuals > 3 > income Statement > net Income
870602
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
0
Annuals > 3 > income Statement > shares Outstanding
0
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-3579.0476190476193
Annuals > 3 > income Statement > total Other Income Expense Net
878118
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
0
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
0
Annuals > 3 > balance Sheet > total Current Assets
162739
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
162739
Annuals > 3 > balance Sheet > payables
98580
Annuals > 3 > balance Sheet > short Term Debt
0
Annuals > 3 > balance Sheet > long Term Debt
0
Annuals > 3 > balance Sheet > total Liabilities
124785
Annuals > 3 > balance Sheet > equity
37804
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
870602
Annuals > 3 > cash Flow > depreciation
0
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
846182
Annuals > 3 > cash Flow > capital Expenditures
89649
Annuals > 3 > cash Flow > cash From Investing
-76296
Annuals > 3 > cash Flow > cash From Financing
-846192
Annuals > 3 > cash Flow > net Change In Cash
-8
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
0
Annuals > 3 > ratios > ROE
2302.9361972278066
Annuals > 3 > ratios > ROA
534.9682620637954
Annuals > 3 > ratios > FCF
756533
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
3602.538095238095
Annuals > 3 > health Score
53
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
-5.732361848220443
Profitability > metrics > ROA
-4.026459470456765
Profitability > metrics > Net Margin
-0.1569225516043562
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.549924140205691
Risk > metrics > Interest Coverage
-13.476126126126125
Risk > final Score
-6
Risk > verdict
High
Liquidity > metrics > Current Ratio
8.240182432854574
Liquidity > metrics > Quick Ratio
4.952788209894969
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
40
Prev Profitabilities > 1
75
Prev Profitabilities > 2
27
Prev Risks > 0
13
Prev Risks > 1
94
Prev Risks > 2
53
Prev Liquidities > 0
84
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:51:59.072Z
Earnings History > 0 > period
2013-06-30
Earnings History > 0 > report Date
2013-08-20
Earnings History > 0 > date
2013-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2013-03-31
Earnings History > 1 > report Date
2013-06-30
Earnings History > 1 > date
2013-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2012-12-31
Earnings History > 2 > report Date
2013-02-20
Earnings History > 2 > date
2012-12-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0.12
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.12
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2012-06-30
Earnings History > 3 > report Date
2012-08-04
Earnings History > 3 > date
2012-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0.2
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0.2
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2012-03-31
Earnings History > 4 > report Date
2012-06-06
Earnings History > 4 > date
2012-03-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.04
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.04
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2011-12-31
Earnings History > 5 > report Date
2012-03-31
Earnings History > 5 > date
2011-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0396
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.0396
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2011-09-30
Earnings History > 6 > report Date
2011-12-31
Earnings History > 6 > date
2011-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.066
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.066
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2011-06-30
Earnings History > 7 > report Date
2011-09-30
Earnings History > 7 > date
2011-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0212
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.0212
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2010-12-31
Earnings History > 8 > report Date
2011-03-31
Earnings History > 8 > date
2010-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0148
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0148
Earnings History > 8 > surprise Percent
-
FusionPharm, Inc. develops, manufactures, and sells a line of cultivation containers under the PharmPod brand name in the United States. Its PharmPods cultivation container system is used in the indoor plant cultivation. The company also offers its products to businesses, universities, and individuals to cultivate various plants. FusionPharm, Inc. was formerly known as Baby Bee Bright Corp. and changed its name to FusionPharm, Inc. in April 2011. The company was founded in 1998 and is based in Commerce City, Colorado.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 4
(Last Updated 2014-03-31)
Health Score
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Fusion Pharm Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2013-06-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2014-03-31)
(Last Updated 2014-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2014-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2014-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.